Jefferson Nóbrega

Jefferson Nóbrega

Auto-generated profile, based on publicly available information

Jefferson Nóbrega

Department of Pharmaceutical Science, Health Sciences Center, Federal University of Paraíba, João Pessoa, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
LCLAÍSA CORDEIRO
LAÍSA CORDEIRO
PFPedro Figueiredo
Pedro Figueiredo
HSHelivaldo Souza
Helivaldo Souza
Aleson Pereira de SousaAleson Pereira de Sousa
Aleson Pereira de Sousa
FJFrancisco Patricio De Andrade Júnior
Francisco Patricio De Andrade Júnior
ELEdeltrudes De Lima Oliveira Lima
Edeltrudes De Lima Oliveira Lima
Staphylococcus aureus is able to rapidly develop mechanisms of resistance to various drugs and to form strong biofilms, which makes it necessary to develop new antibacterial drugs. The essential oil of Melaleuca alternifolia is used as an antibacterial, a property believed to be mainly due to the presence of terpinen-4-ol. Based on this, the objective of this study was to evaluate the antibacterial and antibiofilm potential of terpinen-4-ol against S. aureus. The Minimal Inhibitory and Minimal Bactericidal Concentrations (MIC and MBC) of terpinen-4-ol were determined, and the effect of its combination with antibacterial drugs as well as its activity against S. aureus biofilms were evaluated. In addition, an in silico analysis of its pharmacokinetic parameters and a molecular docking analysis were performed. Terpinen-4-ol presented a MIC of 0.25% (v/v) and an MBC of 0.5% (v/v) (bactericidal action); its association with antibacterials was also effective. Terpinen-4-ol has good antibiofilm activity, and the in silico results indicated adequate absorption and distribution of the molecule in vivo. Molecular docking indicated that penicillin-binding protein 2a is a possible target of terpinen-4-ol in S. aureus. This work highlights the good potential of terpinen-4-ol as an antibacterial product and provides support for future pharmacological studies of this molecule, aiming at its therapeutic application.

23 October 2020 in Natural Product Research
Verified
Journal Article
Closed access
JNJefferson Rodrigues Nóbrega
Jefferson Rodrigues Nóbrega
DSDaniele de Figuerêdo Silva
Daniele de Figuerêdo Silva
FJFrancisco Patricio de Andrade Júnior
Francisco Patricio de Andrade Júnior
PSPaula Mariane Silva Sousa
Paula Mariane Silva Sousa
PFPedro Thiago Ramalho de Figueiredo
Pedro Thiago Ramalho de Figueiredo
ELEdeltrudes De Lima Oliveira Lima
Edeltrudes De Lima Oliveira Lima
The genus Candida is one of the main causes of otomycosis. The growing index of fungal strains resistant to antifungals makes necessary the search for new agents and α-pinene is a phytoconstituent present in plants with remarkable antimicrobial activity, which becomes an interesting object of study. Thus, the objective of this research was to evaluate the antifungal activity of α-pinene against Candida species isolated from otomycosis, determining the Minimum Inhibitory and Fungicide Concentrations, micromorphological analysis and verifying the effects of the association with boric acid. α-pinene showed significant antifungal activity, with greater inhibitory activity against C. parapsilosis, fungicidal action and proved to be effective in inhibiting fungal structures, such as pseudo-hyphae and promoting a marked decrease in blastoconidia. The combination of α-pinene with boric acid produced additive effects that may be interesting for use in clinical practice. Graphical Abstract

Verified
Journal Article
Open access
PDF file
DSDaniele Silva
Daniele Silva
HNHermes Diniz Neto
Hermes Diniz Neto
LCLAÍSA CORDEIRO
LAÍSA CORDEIRO
MSMaria Silva-Neta
Maria Silva-Neta
SSShellygton Silva
Shellygton Silva
ELEdeltrudes De Lima Oliveira Lima
Edeltrudes De Lima Oliveira Lima
The enantiomers (R)-(+)-β-citronellol and (S)-(−)-β-citronellol are present in many medicinal plants, but little is understood about their bioactivity against Candida yeasts. This study aimed to evaluate the behavior of positive and negative enantiomers of β-citronellol on strains of Candida albicans and C. tropicalis involved in candidemia. The minimum inhibitory concentration (MIC) and minimum fungicide concentration (MFC) were determined. The evaluation of growth kinetics, mechanism of action, and association studies with Amphotericin B (AB) using the checkerboard method was also performed. R-(+)-β-citronellol and S-(−)-β-citronellol presented a MIC50% of 64 µg/mL and a MFC50% of 256 µg/mL for C. albicans strains. For C. tropicalis, the isomers exhibited a MIC50% of 256 µg/mL and a MFC50% of 1024 µg/mL. In the mechanism of action assay, both substances displayed an effect on the fungal membrane but not on the fungal cell wall. Synergism and indifference were observed in the association of R-(+)-β-citronellol and AB, while the association between S-(−)-β-citronellol and AB displayed synergism, additivity, and indifference. In conclusion, both isomers of β-citronellol presented a similar profile of antifungal activity. Hence, they can be contemplated in the development of new antifungal drugs providing that further research is conducted about their pharmacology and toxicity.

3 October 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
DMDaianne Medeiros
Daianne Medeiros
JOJosé Oliveira-Júnior
José Oliveira-Júnior
JNJefferson Nóbrega
Jefferson Nóbrega
LCLAÍSA CORDEIRO
LAÍSA CORDEIRO
JJJeane Jardim
Jeane Jardim
ELEdeltrudes De Lima Oliveira Lima
Edeltrudes De Lima Oliveira Lima
Isougenol is a phytoconstituent found in several essential oils. Since many natural products are potent antimicrobials, the synthesis of hybrid molecules—combining the chemical skeleton of the phytochemical with synthetic groups—can generate substances with enhanced biological activity. Based on this, the objective of this study was to evaluate the antifungal activity of isoeugenol and hybrid acetamides against Candida albicans isolated from the oral cavity. The methodologies used were the determination of minimum inhibitory concentration (MIC), minimum fungicidal concentration (MFC), action on fungal micromorphology, interaction test with nystatin by the checkerboard method and molecular docking study with important enzymes in the maintenance of fungal viability. The synthetic molecules did not demonstrate significant antifungal activity in vitro. The isoeugenol MIC and MFC varied between 128 and 256 µg/mL, being the phytoconstituent able to interfere in the formation of blastoconid and chlamydoconid structures, important in the pathogenic process of the species. The molecular docking study revealed that isoeugenol is a potential inhibitor of the enzymes 14-α-demethylase and delta-14-sterol reductase, interfering in the fungal cell membrane biosynthesis. Thus, this research provides clearer expectations for future pharmacological studies with isoeugenol and derived molecules, aiming at its therapeutic application against infections caused by Candida spp.

15 November 2019 in Scientia Plena
Verified
Journal Article
Open access
PDF file
JNJefferson Rodrigues Nóbrega
Jefferson Rodrigues Nóbrega
PSPaula Mariane Silva Sousa
Paula Mariane Silva Sousa
KMKelly Samara de Lira Mota
Kelly Samara de Lira Mota
LCLaísa Vilar Cordeiro
Laísa Vilar Cordeiro
FJFrancisco Patricio de Andrade Júnior
Francisco Patricio de Andrade Júnior
WOWylly Araújo de Oliveira
Wylly Araújo de Oliveira
Antifungal activity of carvacrol and antifungal agent combinations against non-albicans Candida species

1 July 2024 in OBSERVATÓRIO DE LA ECONOMÍA LATINOAMERICANA
Verified
Journal Article
Open access
PDF file
DMDaianne de Sousa Medeiros
Daianne de Sousa Medeiros
JJJosé Klidenberg Oliveira Júnior
José Klidenberg Oliveira Júnior
JNJefferson Rodrigues Nobrega
Jefferson Rodrigues Nobrega
ELEdeltrudes De Lima Oliveira Lima
Edeltrudes De Lima Oliveira Lima
Oral candidiasis is an opportunistic fungal infection that typically affects immunocompromised patients and is caused by yeasts of the genus Candida. Although Candida albicans is the primary etiological agent of oral candidiasis, non-albicans species, such as C. tropicalis and C. glabrata, have been frequently isolated from individuals with this disease. The goal of the present study was to assess the antifungal activity of isoeugenol, determine its effect on the micromorphology of the mouth isolates C. tropicalis and C. glabrata and observe its combined effect with the standard antifungal medication nystatin. The antifungal activity of isoeugenol was tested using the broth microdilution method, and its effect on the micromorphology of pathogenic structures (blastoconidia and pseudohyphae) of C. tropicalis was also assessed. The fractional inhibitory concentration index (FICI) of isoeugenol and nystatin was determined using the checkerboard method. The results showed that isoeugenol had an antifungal effect, with minimum inhibitory concentrations (MICs) ranging from 128 to 256 µg/mL for C. tropicalis and C. glabrata. The minimum fungicidal concentration (MFC) of isoeugenol ranged from 128 to 512 µg/mL for C. tropicalis and from 128 to 256 µg/mL for C. glabrata. In addition, isoeugenol altered the micromorphology of the analyzed fungal isolates. The combination of isoeugenol and nystatin showed synergistic activity against C. tropicalis LM-211 (FICI=0.25). The results of this study revealed that isoeugenol is a phytochemical with effective antifungal activity against Candida spp. and has a high potential for use as an antifungal medication.